CRISPR/Cas9 β-globin gene targeting in human haematopoietic stem cells
Top Cited Papers
- 7 November 2016
- journal article
- research article
- Published by Springer Science and Business Media LLC in Nature
- Vol. 539 (7629), 384-389
- https://doi.org/10.1038/nature20134
Abstract
The β-haemoglobinopathies, such as sickle cell disease and β-thalassaemia, are caused by mutations in the β-globin (HBB) gene and affect millions of people worldwide. Ex vivo gene correction in patient-derived haematopoietic stem cells followed by autologous transplantation could be used to cure β-haemoglobinopathies. Here we present a CRISPR/Cas9 gene-editing system that combines Cas9 ribonucleoproteins and adeno-associated viral vector delivery of a homologous donor to achieve homologous recombination at the HBB gene in haematopoietic stem cells. Notably, we devise an enrichment model to purify a population of haematopoietic stem and progenitor cells with more than 90% targeted integration. We also show efficient correction of the Glu6Val mutation responsible for sickle cell disease by using patient-derived stem and progenitor cells that, after differentiation into erythrocytes, express adult β-globin (HbA) messenger RNA, which confirms intact transcriptional regulation of edited HBB alleles. Collectively, these preclinical studies outline a CRISPR-based methodology for targeting haematopoietic stem cells by homologous recombination at the HBB locus to advance the development of next-generation therapies for β-haemoglobinopathies.Keywords
This publication has 50 references indexed in Scilit:
- CRISPR/Cas9 systems targeting β-globin and CCR5 genes have substantial off-target activityNucleic Acids Research, 2013
- Gene therapy for PIDs: Progress, pitfalls and prospectsGene, 2013
- A Programmable Dual-RNA–Guided DNA Endonuclease in Adaptive Bacterial ImmunityScience, 2012
- Transfusion independence and HMGA2 activation after gene therapy of human β-thalassaemiaNature, 2010
- Collaboration and competition between DNA double‐strand break repair pathwaysFEBS Letters, 2010
- Hematopoietic stem cell: self‐renewal versus differentiationWires Systems Biology and Medicine, 2010
- Allogeneic haematopoietic stem cell transplantation: individualized stem cell and immune therapy of cancerNature Reviews Cancer, 2010
- Identification of a Hierarchy of Multipotent Hematopoietic Progenitors in Human Cord BloodCell Stem Cell, 2007
- Therapeutic gene causing lymphomaNature, 2006
- Chimeric Nucleases Stimulate Gene Targeting in Human CellsScience, 2003